Get the full picture
Sign in to uncover key details.
Aro Biotherapeutics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
170 S Independence Mall W Ste 740, Phila...Phone Number
(215) 544-1175Website
www.arobiotx.comRevenue
<$5 MillionIndustry
About Aro Biotherapeutics
Aro Biotherapeutics is a biotechnology company based in Philadelphia that specializes in the development of tissue-targeted genetic medicines using its proprietary Centyrin technology. The company focuses on creating a pipeline of Centyrin-based therapeutic candidates aimed at addressing challenging diseases through selective modulation of gene targets. Aro collaborates with industry partners to enhance the tissue-specific targeting of therapeutics. Their innovative approach aims to achieve superior efficacy and safety in treating various conditions.Explore more
Aro Biotherapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Aro Biotherapeutics
Compare insights from companies similar to Aro Biotherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$132.7M
51-200
Public
$547.1M
1994
JB
Jennifer BuellPresident and CEO of MiNK Therapeutics, Chairman, Executive Council At Agenus
Aro Biotherapeutics Tech Stack
A closer look at the technologies used by Aro Biotherapeutics
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aro Biotherapeutics
Sign Up For FreeTo access detailed company insights
Aro Biotherapeutics is a biotechnology company based in Philadelphia that specializes in the development of tissue-targeted genetic medicines using its proprietary Centyrin technology. The company focuses on creating a pipeline of Centyrin-based therapeutic candidates aimed at addressing challenging diseases through selective modulation of gene tar... Read More
